期刊文献+

临床外科护理在膀胱肿瘤治疗过程中的应用体会 被引量:1

Application Experience of Nursing of Clinical Surgery in the Treatment of Tumor of Bladder
下载PDF
导出
摘要 目的对在膀胱肿瘤疾病护理成效进行综合分析。方法选择的研究对象是近三年来在我院接受过膀胱肿瘤治疗的患者,进行临床外科护理划分为实验组,未进行的划分为对照组。结果在实验组的48例患者中恢复健康35例,约占73%,11例出现轻微并发症,约占23%;在对照组的30例患者中恢复健康15例,占50%,9例产生轻微并发症,占30%,6例产生严重并发症甚至复发的,占20%,通过及时治疗和精心的护理全部顺利通过围手术期,达到出院标准。结论应用临床外科护理对肿瘤疾病的整个治疗过程都有显著疗效,提高了整个疾病的治愈率。 ObjectiveTo comprehensive analysis the effect of nursing in tumor of bladder.MethodsThe object of study was received the treatment of bladder cancer in the recent three years in our hospital. Who treated with clinical surgical nursing are divided into the experimental group, others are divided into the experimental group the control group. Results In 48 cases of experimental group,35 cases(73%) were restored to health, 11 patients(23%) were occurred in minor complications. In 30 cases of control group,15 cases(50%) were restored to health, 9 patients(30%) were occurred in minor complications,6 cases(20%) were in serious complications.Conclusion The clinical application of surgical nursing of tumor throughout the course of treatment of disease have a signiifcant effect. Improve the cure rate of the disease.
作者 郝晓彬
出处 《中国继续医学教育》 2015年第6期157-158,共2页 China Continuing Medical Education
关键词 膀胱肿瘤 治疗 临床外科护理 Tumor of bladder Treatment Nursing of clinical surgery
  • 相关文献

参考文献3

二级参考文献24

  • 1郝鹏,秦迎春,宋革.膀胱肿瘤术后不同药物膀胱灌注的临床观察[J].黑龙江医药科学,2005,28(6):71-72. 被引量:7
  • 2Amit D, Hochberg A. Development of targeted thera- py for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences[J]. J Transl Med, 2010, 8: 134.
  • 3Masood S, Sriprasad S, Palmer J H, et al. TIG3 blad- der cancer-indications for early cystectomy[J]. Int Urol Nephrol, 2004, 36(1): 41-44.
  • 4Pfost B, Seidl C, Autenrieth M, et al. Intravesical alpha-radioimmunotherapy with 213Bi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice[J]. J Nucl Med, 2009, 50(10): 1700-1708.
  • 5Huncharek M, Geschwind J F, Witherspoon B, et al. Intravesical chemotherapy prophylaxis in primary su- perficial bladder cancer: a meta-analysis of 3703 patients from 11 randomized trials[J]. J Clin Epidemiol, 2000, 53(7): 676m680.
  • 6Weizer A Z, Tallman C, Montgomery J S. Long-term outcomes of intravesical therapy for non-muscle inva- sive bladder caneer[J]. World J Urol, 2011, 29(1): 59 -71.
  • 7Okamura T, Akita H, Ando R, et al. Single monthly bacillus Calmette-Guerin intravesical instillation is ef- fective maintenance therapy to prevent recurrence in Japanese patients with non-muscle-invasive bladder cancer[J]. Int J Clin Oncol, 2012, 17(5): 477-481.
  • 8Nakai Y, Nonomura N, Kawashima A, et al. Tumor multiplicity is an independent prognostic factor of non- muscle-invasive high-grade (T1G3) bladder cancer[J]. Jpn J Clin oncol, 2010, 40(3): 252-257.
  • 9McHugh L A, Grifiths T R. TIG3 transitional cell carcinoma of the bladder: recurrence, progression and survival[J]. BJU Int, 2004, 94(1): 193.
  • 10Yao Y, Zhao H, Sun Y, et ak Combined chemothera- py of hydroxycampothecin with oxaliplatin as an adju- vant treatment for human colorectal cancer[J]. Tohoku J Exp Med, 2008, 215(3): 267-278.

共引文献450

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部